‘The devil is in the details’

Canadians may see simplified drug patent rules under a free trade pact with Europe, say the nation’s largest pharmaceutical associations. Generic and brand-name drug makers told Blacklock’s they anticipate the treaty will limit multiple lawsuits over patents: “The government has promised us…”

This content is for Blacklock’s Reporter members only. Please login to view this content. (Register here.)

Back to Top